GABA Calm Orange Flavor

GABA Calm Orange Flavor

Format:Lozenge Quantity: 120 Liquid(s) · 120 servings
Goals

Product analysis

52 out of 100

GABA Calm Orange Flavor offers an orange-flavored lozenge with limited support for short-term calming during stressful tasks.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality24

Most ingredient forms, including GABA, are undisclosed, leaving their quality uncertain. Magnesium has a named form, but its quality is not established.

Ingredient Transparency70

All listed amounts are stated, making the serving contents easier to check. Only magnesium has a named form, leaving the other preparations unclear.

Value For Money49

The serving price is reasonably favorable for GABA but high relative to the small glycine amount. Value for the other ingredients remains uncertain.

Customer Satisfaction81

Customer ratings are generally positive. Thousands of responses give a broad view of satisfaction.

Product Focus58

The main potential is short-term calming through GABA, with more uncertain mood and sleep effects. The GABA serving is below the relevant comparison amount, and the small amounts of other nutrients add little separate sleep support.

Format
Lozenge
Container
120 Liquid(s)
Per serving
$0.15
Customer rating
4.5 · 3,158 ratings
Report analysis

Goals

Stress Relief
Impact
High effect
C+ Ingredient FitD- PathwaysA EvidenceA+ Formulation Logic
Magnesium · 5 mgGlycine · 50 mgGABA · 125 mg
Study evidence
GABA Supportive 6 studies
Glycine Supportive 1 study
Magnesium Supportive 13 studies
Taurine Supportive 5 studies
Mood Support
Impact
Moderate effect
B Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic
Magnesium · 5 mg
Study evidence
GABA Supportive 12 studies
Glycine Mixed 3 studies
Magnesium Supportive 60 studies
Sleep Support
Impact
Moderate effect
C Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic
Magnesium · 5 mgGlycine · 50 mg
Study evidence
GABA Supportive 4 studies
Glycine Supportive 3 studies
Magnesium Supportive 23 studies
Taurine Not classified

No linked studies yet.

Ingredients

IngredientAmount per servingScore
Magnesium (Magnesium Chelate)
5 mg
GABA
125 mg 75
Glycine
50 mg 24
N-Acetyl L-Tyrosine
25 mg
Taurine
20 mg 42
Adults 18–50
Report overview
GABA · 125 mg OverallScore75
B- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB- Value
The selected serving provides 125 mg of GABA at a moderate cost per serving. The GABA is unbranded, and its source is unspecified. The other ingredients include a flow agent.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

The GABA is unbranded and its source is unspecified.
GABA Source & Production Method
The GABA is unbranded and its source is unspecified.

Dose, Safety & Label Transparency82

The serving states 125 mg of GABA. The other ingredients include a flow agent.
GABA Dosage Adequacy & Transparency
The selected serving contains 125 mg of GABA.
Label Purity & Excipient Quality
The other ingredients include a flow agent.

Value70

The cost per serving is moderate.
Price per Effective Dose
The cost per serving is moderate.
Glycine · 50 mg OverallScore24
F Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyF Value
Each serving provides 50 mg of glycine, a small amount. The cost per gram of glycine is high. The available information does not establish a glycine purity certification or grade. Ordinary excipients or capsule materials are recorded, though their identities are unspecified.
How this ingredient is rated

Active Ingredient Quality & Bioavailability0

The available information does not establish a glycine purity certification or grade.
Glycine Sourcing and Purity Standards
The available information does not establish a glycine purity certification or grade.

Dose, Safety & Label Transparency46

Each serving provides 50 mg of glycine, a small amount. Ordinary excipients or capsule materials are recorded, though their identities are unspecified.
Clinically Relevant Dosage
Each serving provides 50 mg of glycine, a small amount.
Label Transparency and Yield Disclosure
The glycine amount is stated as 50 mg per serving.
Clean Label and Excipient Quality
Ordinary excipients or capsule materials are recorded, though their identities are unspecified.

Value30

The cost per gram of glycine is high.
Cost Efficiency per 1,000mg of Glycine
The cost per gram of glycine is high.
Taurine · 20 mg OverallScore42
D+ Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value
The serving lists 20 mg of taurine, a small amount. The estimated cost for the taurine amount is high. The more specific form is unclear. A standard flow agent is indicated, but its name is unclear.
How this ingredient is rated

Active Ingredient Quality & Bioavailability51

Taurine is named, but a free-form or purity grade is not documented. The taurine source and manufacturing origin are unclear. A standard flow agent is indicated, but its name is unclear.
Chemical Form and Purity
Taurine is named, but a free-form or purity grade is not documented.
Sourcing and Branded Ingredients
The taurine source and manufacturing origin are unclear.
Formulation Cleanliness
A standard flow agent is indicated, but its name is unclear.

Dose, Safety & Label Transparency45

The serving lists 20 mg of taurine, a small amount. A third-party certification or testing claim is not documented.
Taurine Dosage Potency
The serving lists 20 mg of taurine, a small amount.
Dose Disclosure
The taurine amount per serving is stated.
Quality Assurance and Testing
A third-party certification or testing claim is not documented.

Value20

The estimated cost for the taurine amount is high.
Price per Gram of Taurine
The estimated cost for the taurine amount is high.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks.
    Yoto A; Murao S; Motoki M; Yokoyama Y; Horie N; Takeshima K; Masuda K; Kim M; Yokogoshi H · Amino acids · 2012
    Randomized trial63 participantsMood Support Stress Relief forGABA
  2. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.
    Deligiannidis KM; Kroll-Desrosiers AR; Mo S; Nguyen HP; Svenson A; Jaitly N; Hall JE; Barton BA; Rothschild AJ; Shaffer SA · Psychoneuroendocrinology · 2017
    Cohort study56 participantsMood Support forGABA
  3. The role of neurotransmitters in mediating the relationship between brain alterations and depressive symptoms in patients with inflammatory bowel disease.
    Wang J; Liu G; Xu K; Ai K; Huang W; Zhang J · Human brain mapping · 2023
    Case-control study69 participantsMood Support forGABA
  4. Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis.
    Truong V; Cheng PZ; Lee HC; Lane TJ; Hsu TY; Duncan NW · Psychiatry research. Neuroimaging · 2021
    Observational studyMood Support forGABA
  5. Systematic review of gamma-aminobutyric-acid inhibitory deficits across the reproductive life cycle.
    Vigod SN; Strasburg K; Daskalakis ZJ; Blumberger DM · Archives of women's mental health · 2014
    Systematic review11 studies pooledMood Support forGABA
  6. [Augmentation of antipsychotics with glycine may ameliorate depressive and extrapyramidal symptoms in schizophrenic patients--a preliminary 10-week open-label study].
    Strzelecki D; Kropiwnicki P; Rabe-Jabłońska J · Psychiatria polska · 2014
    Single-arm trial29 participantsMood Support forGlycine
  7. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls.
    Pålsson E; Jakobsson J; Södersten K; Fujita Y; Sellgren C; Ekman CJ; Ågren H; Hashimoto K; Landén M · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2015
    Cross-sectional study327 participantsMood Support forGlycine
  8. Erythrocyte glycine in depressed, hypomanic, and euthymic bipolar patients treated with lithium carbonate.
    Peselow ED; Deutsch SI; Stanley M; Banay-Schwartz M; Virgilio J; Fieve RR · Psychopharmacology · 1983
    Cross-sectional study27 participantsMood Support forGlycine
  9. Protective role of antioxidant supplementation for depression and anxiety: A meta-analysis of randomized clinical trials.
    Wang H; Jin M; Xie M; Yang Y; Xue F; Li W; Zhang M; Li Z; Li X; Jia N; Liu Y; Cui X; Hu G; Dong L; Wang G; Yu Q · Journal of affective disorders · 2023
    Meta-analysis4,049 participants52 studies pooledMood Support forMagnesium
  10. Role of magnesium supplementation in the treatment of depression: A randomized clinical trial.
    Tarleton EK; Littenberg B; MacLean CD; Kennedy AG; Daley C · PloS one · 2017
    Randomized trial126 participantsMood Support Stress Relief forMagnesium
  11. Magnesium supplementation as an adjunct to fluoxetine therapy for depression.
    Walyddaini AS; Lisal ST; Ilhamuddin; Zainuddin AA; Tanra AJ; Widianingsih Y; Syamsuddin S · East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan · 2026
    Randomized trial40 participantsMood Support forMagnesium
  12. The effects of magnesium supplementation on serum level of brain derived neurotrophic factor (BDNF) and depression status in patients with depression.
    Afsharfar M; Shahraki M; Shakiba M; Asbaghi O; Dashipour A · Clinical nutrition ESPEN · 2021
    Randomized trial46 participantsMood Support forMagnesium
  13. Dietary magnesium intake and risk of depression.
    Sun C; Wang R; Li Z; Zhang D · Journal of affective disorders · 2019
    Cross-sectional study17,730 participantsMood Support forMagnesium
  14. Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial.
    Byun JI; Shin YY; Chung SE; Shin WC · Journal of clinical neurology (Seoul, Korea) · 2020
    Randomized trial40 participantsSleep Support forGABA
  15. Analysis of the Effects of Known Sleep-Support Supplements in Relation to Life Habits, Sleep Conditions, and Sleep Problems.
    Imafuku F; Yamamoto K; Tanaka E; Aoki R; Nishino S · Nutrients · 2023
    Randomized trial160 participantsSleep Support forGABA
  16. Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?
    Plante DT; Jensen JE; Schoerning L; Winkelman JW · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Case-control study40 participantsSleep Support forGABA
  17. GABA Supplementation, Increased Heart-Rate Variability, Emotional Response, Sleep Efficiency and Reduced Depression in Sedentary Overweight Women Undergoing Physical Exercise: Placebo-Controlled, Randomized Clinical Trial.
    Guimarães AP; Seidel H; Pires LVM; Trindade CO; Baleeiro RDS; Souza PM; Silva FGDE; Coelho DB; Becker LK; Oliveira EC · Journal of dietary supplements · 2024
    Randomized trial30 participantsSleep Support Stress Relief forGABA
  18. The effect of glycine administration on the characteristics of physiological systems in human adults: A systematic review.
    Soh J; Raventhiran S; Lee JH; Lim ZX; Goh J; Kennedy BK; Maier AB · GeroScience · 2024
    Systematic reviewSleep Support forGlycine
  19. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep.
    Bannai M; Kawai N · Journal of pharmacological sciences · 2012
    Narrative reviewSleep Support forGlycine
  20. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers.
    Bannai M; Kawai N; Ono K; Nakahara K; Murakami N · Frontiers in neurology · 2012
    Clinical trial7 participantsSleep Support forGlycine